Antibody testing in Denmark suggests an estimated 3.5% of the population infected as of March 26, 30-70X the number of cases identified through the normal testing process.
As mentioned, the specificity of the antibody test really matters. For a 2% true prevalence in the population, if the test is 99% sensitive and 95% specific, the test will show something like a 7% prevalence. It's really not very good at getting accurate prevalence numbers when the prevalence is low.
Not sure how firm the 30-80 times range is... One paragraph further down the range 30-70 times is used. Possible the range is very uncertain due to lack of testing. They intend to do a lot more testing.
Looks like a repeat post of above.
Hell, spend one freaking trillion $$$ protecting those that are at risk in this event (65+ and sick) and let the rest of the people go back to work.
This seems like a bad strategy, as it would be very hard to avoid such outbreaks if you just let the virus circulate elsewhere. The money is much better spent on actually solving the problem.
I still can't get around the fact that no one gave a crap about the 60K mostly old+sick people who died from the flu in 2017-2018
People did care a lot about that. That's why we have massive immunization campaigns every year, which saves many 10s of thousands of lives. Putting aside the hospital issue, the issue here with SARS-CoV-2 is that about 2 million these old & sick people would have died if we had let this go. That's a lot more than 60k.
In addition, you'd be losing about 200k people who were below ~65. And about 50k of these would have been 100% healthy individuals with no comorbidities.
These numbers are rough, but based on the best available evidence to date.
Looks like travel from Europe should have been halted back in February as researchers say the virus genome came from there not Asia in the case of East Coast spread.
Yeah, I posted that data
a few days back in this thread. I guess I scooped the NY Times! Sadly I did not publish my armchair virologist conclusion. Anyway, it was pretty evident from the Nextstrain data a week ago, and more genomes have come in since then. Not sure why the NY Times is only publishing that information now. Probably they had to double check with the experts.
Regarding timing of those introductions, it's a bit harder to determine. With lots of introductions (seems like at least 10, probably more), it's possible that the introductions could have started occurring in February. But would not be surprised if they actually started in January. The beginning of outbreaks tends to be fairly stochastic since a single introduction can either just fizzle, or it can explode in the case of a super-spreading. So the exact timing is hard to pin down. With more genome sampling they could probably be more precise, but they'd need genomes from back in February to be more definitive I think - such virus samples may exist somewhere incidentally, but just haven't been sequenced.